Home/Filings/4/0001613377-18-000021
4//SEC Filing

PASCALE ADAM 4

Accession 0001613377-18-000021

CIK 0000946644other

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 10:57 AM ET

Size

5.3 KB

Accession

0001613377-18-000021

Insider Transaction Report

Form 4
Period: 2018-10-17
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2018-10-17+94,69794,697 total
    Exercise: $0.22From: 2018-10-17Exp: 2028-10-17Common Stock (94,697 underlying)
Footnotes (1)
  • [F1]This option is being issued to senior management in exchange for a voluntary 50% deferral in salary.

Issuer

HEMISPHERX BIOPHARMA INC

CIK 0000946644

Entity typeother

Related Parties

1
  • filerCIK 0001613377

Filing Metadata

Form type
4
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 10:57 AM ET
Size
5.3 KB